Volumetric Absorptive Microsampling: A New Sampling Tool for Therapeutic Drug Monitoring of Antiepileptic Drugs

被引:46
作者
D'Urso, Annachiara [1 ]
Rudge, James [2 ]
Patsalos, Philip N. [3 ,4 ]
de Grazia, Ugo [1 ]
机构
[1] Fdn IRCCS Ist Neurol Carlo Besta, Lab Neurol Biochem & Neuropharmacol, Milan, Italy
[2] Neoteryx LLC, Torrance, CA USA
[3] UCL, Inst Neurol, Queen Sq, London, England
[4] Chalfont Ctr Epilepsy, Therapeut Drug Monitoring Unit, Gerrards Cross, England
关键词
YAMS; TDM; AEDs; bioanalytical method validation; microsampling; CLINICAL PHARMACOKINETICS; WHOLE-BLOOD; QUANTITATIVE BIOANALYSIS; MAJOR METABOLITES; INTERNAL STANDARD; MASS-SPECTROMETRY; ALTERNATIVE TOOL; VALPROIC ACID; LC-MS/MS; PLASMA;
D O I
10.1097/FTD.0000000000000652
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Volumetric absorptive microsampling (YAMS) is a novel sampling technique for the collection of fixed-volume capillary blood. In this study, a new analytical method was developed and used to quantify 14 different antiepileptic drugs (AEDs) and 2 active metabolites in samples collected by YAMS. These data were compared with concentration measurements in plasma. Methods: The authors developed a selective and sensitive liquid chromatography-mass spectrometry (LC-MS/MS) assay to measure the concentrations of several AEDs in whole blood collected by YAMS, which were compared with a commercially available LC-MS/MS kit for AED monitoring in plasma. Drugs and internal standards were extracted from whole blood/plasma samples by a simple protein precipitation. Results: An LC-MS/MS method analyzing YAMS samples was successfully developed and validated for the determination of various AED concentrations in whole blood according to EMA guidelines for bioanalytical method validation. Extraction recovery was between 91% and 110%. No matrix effect was found. The method was linear for all drugs with R-2 >= 0.989 in all cases. Intra-assay and inter-assay reproducibility analyses demonstrated accuracy and precision within acceptance criteria. Carry over and interferences were negligible. No volumetric HCT% bias was found at 3 different HCT values (35%-55%) with recovery being consistently above 87%. Samples are very stable at temperatures ranging from -20 degrees C to 37 degrees C and for a 4-month period. Leftover EDTA samples from 133 patients were tested to determine concentration differences between plasma and whole blood sampled by YAMS. The resulting difference varied less than 15% apart from those drugs with a blood/plasma ratio (R) different from 1. Conclusions: The assay allows for highly sensitive and selective quantification of several AEDs in whole blood samples collected by YAMS. The developed method is accurate and precise and free from matrix effects and volumetric HCT% bias.
引用
收藏
页码:681 / 692
页数:12
相关论文
共 41 条
[1]   Investigation of Different Approaches to Incorporating Internal Standard in DBS Quantitative Bioanalytical Workflows and Their Effect on Nullifying Hematocrit-Based Assay Bias [J].
Abu-Rabie, Paul ;
Denniff, Philip ;
Spooner, Neil ;
Chowdhry, Babur Z. ;
Pullen, Frank S. .
ANALYTICAL CHEMISTRY, 2015, 87 (09) :4996-5003
[2]   A Simple Dried Blood Spot Assay for Therapeutic Drug Monitoring of Lamotrigine [J].
AbuRuz, Salah ;
Al-Ghazawi, Mutasim ;
Al-Hiari, Yousef .
CHROMATOGRAPHIA, 2010, 71 (11-12) :1093-1099
[3]  
AlMekdad D, 2016, MASS SPECTR APPL CLI
[4]  
[Anonymous], 1993, R241993 CRB RUEIL MA
[5]   CLINICAL PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS IN PEDIATRIC-PATIENTS .1. PHENOBARBITAL, PRIMIDONE, VALPROIC ACID, ETHOSUXIMIDE AND MESUXIMIDE [J].
BATTINO, D ;
ESTIENNE, M ;
AVANZINI, G .
CLINICAL PHARMACOKINETICS, 1995, 29 (04) :257-286
[6]   DISTRIBUTION OF CARBAMAZEPINE AND ITS EPOXIDE IN BLOOD COMPARTMENTS IN ADOLESCENT AND ADULT EPILEPTIC PATIENTS [J].
BONNETON, J ;
GENTON, P ;
MESDJIAN, E .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1992, 13 (06) :411-416
[7]  
BUCHANAN RA, 1973, INT J CLIN PHARM TH, V7, P213
[8]   Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration [J].
Cawello, Willi ;
Boekens, Hilmar ;
Bonn, Rainer .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2012, 37 (04) :241-248
[9]  
De Kesel PMM, 2014, BIOANALYSIS, V6, P1871, DOI [10.4155/bio.14.151, 10.4155/BIO.14.151]
[10]   Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect [J].
De Nicolo, Amedeo ;
Cantu, Marco ;
D'Avolio, Antonio .
BIOANALYSIS, 2017, 9 (14) :1093-1105